###begin article-title 0
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study
###end article-title 0
###begin p 1
These authors contributed equally
###end p 1
###begin p 2
These authors contributed equally
###end p 2
###begin p 3
Contributors
###end p 3
###begin p 4
JBR, FR, MI, TMP, MF, KRA, FZ, and TA did statistical analysis. MI, NS, RG, PW, VK, and PD coordinated genome-wide association genotyping for the TwinsUK discovery cohort. FR, PA, MJ, MM, JBvM, and AGU coordinated genome-wide association genotyping for the Rotterdam cohort and genotyping for the TwinsUK replication and Chingford cohorts. TMP and DJV did expression studies. SGW and BHM contributed to replication genotyping. TMP, SGW, JBvM, AH, HAPP, DH, AGU, and TDS collected data. JBR, FR, TMP, MI, PD, AGU, and TDS contributed to study design. All authors contributed to the analysis and interpretation of results. JBR wrote the report.
###end p 4
###begin title 5
Summary
###end title 5
###begin title 6
Background
###end title 6
###begin p 7
Osteoporosis is diagnosed by the measurement of bone mineral density, which is a highly heritable and multifactorial trait. We aimed to identify genetic loci that are associated with bone mineral density.
###end p 7
###begin title 8
Methods
###end title 8
###begin p 9
###xml 130 135 <span type="species:ncbi:9606">women</span>
###xml 201 207 <span type="species:ncbi:9606">people</span>
In this genome-wide association study, we identified the most promising of 314 075 single nucleotide polymorphisms (SNPs) in 2094 women in a UK study. We then tested these SNPs for replication in 6463 people from three other cohorts in western Europe. We also investigated allelic expression in lymphoblast cell lines. We tested the association between the replicated SNPs and osteoporotic fractures with data from two studies.
###end p 9
###begin title 10
Findings
###end title 10
###begin p 11
###xml 103 105 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 162 171 162 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 427 429 427 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 617 626 617 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 713 716 713 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 746 748 746 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 899 908 899 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 955 957 955 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1125 1128 1125 1128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;17</sup>
###xml 979 985 <span type="species:ncbi:9606">people</span>
We identified genome-wide evidence for an association between bone mineral density and two SNPs (p<5x10-8). The SNPs were rs4355801, on chromosome 8, near to the TNFRSF11B (osteoprotegerin) gene, and rs3736228, on chromosome 11 in the LRP5 (lipoprotein-receptor-related protein) gene. A non-synonymous SNP in the LRP5 gene was associated with decreased bone mineral density (rs3736228, p=6.3x10-12 for lumbar spine and p=1.9x10-4 for femoral neck) and an increased risk of both osteoporotic fractures (odds ratio [OR] 1.3, 95% CI 1.09-1.52, p=0.002) and osteoporosis (OR 1.3, 1.08-1.63, p=0.008). Three SNPs near the TNFRSF11B gene were associated with decreased bone mineral density (top SNP, rs4355801: p=7.6x10-10 for lumbar spine and p=3.3x10-8 for femoral neck) and increased risk of osteoporosis (OR 1.2, 95% CI 1.01-1.42, p=0.038). For carriers of the risk allele at rs4355801, expression of TNFRSF11B in lymphoblast cell lines was halved (p=3.0x10-6). 1883 (22%) of 8557 people were at least heterozygous for these risk alleles, and these alleles had a cumulative association with bone mineral density (trend p=2.3x10-17). The presence of both risk alleles increased the risk of osteoporotic fractures (OR 1.3, 1.08-1.63, p=0.006) and this effect was independent of bone mineral density.
###end p 11
###begin title 12
Interpretation
###end title 12
###begin p 13
###xml 284 290 <span type="species:ncbi:9606">people</span>
Two gene variants of key biological proteins increase the risk of osteoporosis and osteoporotic fracture. The combined effect of these risk alleles on fractures is similar to that of most well-replicated environmental risk factors, and they are present in more than one in five white people, suggesting a potential role in screening.
###end p 13
###begin title 14
Introduction
###end title 14
###begin p 15
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">6</xref>
###xml 738 739 738 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
Osteoporosis and its main complication, fragility fractures, incur substantial global morbidity and mortality.1 The public-health burden of this disease is US$17 billion every year in direct expenditure-and this is expected to increase dramatically as populations age.2 Osteoporosis is defined clinically through the measurement of bone mineral density, which remains the single best predictor of primary osteoporotic fractures.3 Bone mineral density is highly heritable, with estimates from a cohort study in the UK of 78% heritability of density at lumbar spine and 84% at femoral neck;4 these figures are consistent with other twin studies.5 Only a few well-replicated studies of candidate genes for osteoporosis have so far emerged,6-8 suggesting that bone mineral density is a complex polygenic trait.5
###end p 15
###begin p 16
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
Genome-wide association studies have been facilitated by the HapMap project, and by recent advances in genome-wide genotyping arrays that provide a high degree of genome coverage.9 We therefore undertook a genome-wide association study to identify genetic loci that influence bone mineral density.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants and phenotypes
###end title 18
###begin p 19
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">table 1</xref>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">12</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 49 61 <span type="species:ncbi:9606">participants</span>
###xml 269 274 <span type="species:ncbi:9606">women</span>
###xml 384 387 <span type="species:ncbi:9606">men</span>
###xml 392 397 <span type="species:ncbi:9606">women</span>
###xml 470 478 <span type="species:ncbi:9606">patients</span>
###xml 544 549 <span type="species:ncbi:9606">women</span>
###xml 683 695 <span type="species:ncbi:9606">Participants</span>
###xml 888 900 <span type="species:ncbi:9606">participants</span>
We did a genome-wide association study with 8557 participants, all of whom were of white European ancestry, unselected for any disease or trait, and aged 18 years and older. Baseline characteristics are in table 1 and the webappendix. The discovery cohort consisted of women from the TwinsUK cohort, which was a population-based sample from the UK.4 The replication cohorts comprised men and women from a Dutch population-based study of unrelated and unselected elderly patients (the Rotterdam study),10-12 a population-based sample of British women (the Chingford study),13 and the TwinsUK replication cohort, with individuals who were not included in the TwinsUK discovery cohort. Participants were excluded if they reported use of bisphosphonate medications or corticosteroids. All studies were approved by institutional ethics review committees at the relevant organisations, and all participants provided written informed consent.
###end p 19
###begin p 20
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">14</xref>
We measured bone mineral density in all cohorts at the lumbar spine (L1-4) and femoral neck by dual energy radiograph absorptiometry with standard protocols. In the TwinsUK cohorts, bone mineral density was measured at several time points, so the most recent measurement was used to better match the age range of the other two cohorts. Osteoporosis was defined as a T-score of less than or equal to 2.5 SD at either the femoral neck or lumbar spine site (derived from peak female bone mass).14
###end p 20
###begin p 21
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 929 936 929 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">table 2</xref>
Osteoporotic fractures were defined as site-specific, validated, clinical, low-trauma fractures. All non-osteoporotic site fractures (nose, toe, head, jaw, skull, and hands) were excluded. In the Chingford study, fractures were assessed prospectively by interview at each annual visit and by phone calls every 6 months to reduce information bias.13 We validated reports of fractures from general practitioners' notes with a standardised protocol.13 Fractures were excluded if no radiograph report, hospital letter, or clinical examination was available to confirm the fracture. If notes were missing, all self-reported fractures were coded as missing. The methods used for identification of fractures in the Rotterdam cohort have been described previously.15 In brief, the computerised records of general practitioners and hospital registries were regularly checked by research physicians who reviewed and coded the information (table 2).
###end p 21
###begin title 22
Genotyping and quality control
###end title 22
###begin p 23
###xml 344 346 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
###xml 815 820 <span type="species:ncbi:9606">women</span>
We genotyped samples from the TwinsUK discovery cohort with the Infinium assay (Illumina, San Diego, USA) across three genome-wide SNP sets, after strict quality-control criteria were applied (see webappendix). We retained 314 075 (98.7%) SNPs for analysis. 2704 SNPs were excluded because they violated the Hardy-Weinberg equilibrium (p<1.0x10-4); 733 SNPs were excluded because they had genotype call rates of 90% or less; and 725 SNPs were excluded because they had a minor allele frequency of less than 0.01. We then assayed the 314075 SNPs in the Rotterdam cohort, with the HumanHap 550 v3.0 array (Illumina, San Diego, USA), which contained the same SNPs as the TwinsUK cohort, after applying the same quality-control criteria. The Rotterdam cohort was genotyped in two phases: first with a subsample of 1586 women who were randomly selected from the cohort, and then with the remainder of individuals in the cohort. We genotyped the Chingford and TwinsUK replication cohorts with the Taqman system (Applied Biosystems, Foster City, CA, USA), as described earlier.16,17
###end p 23
###begin title 24
Statistical analysis
###end title 24
###begin p 25
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">19</xref>
###xml 228 234 <span type="species:ncbi:9606">people</span>
We assessed possible confounding bias arising from population substructure by use of the program STRUCTURE in the TwinsUK cohort.18 We assessed bias from identity by state clustering analysis in the Rotterdam study,19 excluding people who were not of European ancestry, and by applying genomic control. Such effects were not evident after exclusions, with genomic inflation factors of 1.04 or less for both phenotypes in both cohorts. Bone mineral density was adjusted for age in all cohorts. We then undertook a genome-wide association scan, accounting for family structure in the discovery population, as implemented in the PLINK software package (version 1.01).19
###end p 25
###begin p 26
###xml 45 53 45 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">figure 1</xref>
###xml 541 543 541 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">20</xref>
###xml 649 650 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 286 291 <span type="species:ncbi:9606">women</span>
We planned a two-stage replication strategy (figure 1). In the first stage we did a genome-wide association scan to select SNPs, based on p values and linkage disequilibrium, from the TwinsUK discovery cohort (webfigure 1). We tested these SNPs for replication in the subsample of 1586 women from the Rotterdam cohort, who had previously been genotyped. In this first stage, we tested the SNPs from the genome-wide association scan that had a false-positive report probability of less than 0.5 (corresponding to a p value threshold of 1.6x10-4 or less; webappendix and webtable 1).20 We also tested SNPs which were in close linkage disequilibrium (r2>/=0.7) with one of the selected SNPs, and for which the p value was 0.001 or lower, for replication in this stage. 39 SNPs for lumbar spine and 60 for femoral neck met these criteria and are displayed in webtable 1.
###end p 26
###begin p 27
###xml 396 408 <span type="species:ncbi:9606">participants</span>
In the second stage of replication testing, we considered at least one SNP from each locus that had a p value of less than 0.05 in the Rotterdam subsample for replication in stage two. Six SNPs (rs2445803, rs3736228, rs6469792, rs6469804, rs11099284, and rs4355801) met these criteria and were tested for their association with bone mineral density in stage two, which incorporated the remaining participants from the Rotterdam cohort, with the Chingford cohort and the Twins UK replication cohort.
###end p 27
###begin p 28
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">23</xref>
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R25">25</xref>
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1091 1092 1091 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 982 985 <span type="species:ncbi:9606">men</span>
###xml 990 995 <span type="species:ncbi:9606">women</span>
Many different replication strategies have been used in genome-wide association scans.21-23 We used 5x10-8 as a threshold for p values (Bonferroni correction, based on 0.05 multiplied by 1 million independent SNPs in the CEU population of the HapMap Phase II).9 This threshold should not only account for the multiple tests required for a typical genome-wide association scan, but also for the additional tests required for replication and functional studies.24 Effect sizes were estimated from the replication cohorts only. p values from each replication phase of the study and each cohort are in webtable 1. The p value for the association between the number of risk alleles and bone mineral density was derived from a non-parametric trend test.25 The p value for the relationship between both risk alleles and bone mineral density is derived from a two-sided Student's t test. All analyses of bone mineral density, unless otherwise stated, were from the combined analysis of the men and women from all cohorts. We used cohort-specific, age-residualised, standardised bone mineral density Z scores (mean 0, SD 1) that were based on the assumption of an additive effect of the risk alleles. Adjustment for age did not modify the association between the replicated SNPs and a diagnosis of osteoporosis (results not shown).
###end p 28
###begin title 29
Expression analysis
###end title 29
###begin p 30
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
###xml 211 220 211 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R27">27</xref>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 384 393 384 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">28</xref>
We used cis-associated allelic expression studies to ascertain whether the risk alleles associated with low bone mineral density affected expression of their nearest transcript in lymphoblast cell lines.26 Only TNFRSF11B was informative in the HapMap CEU lymphoblast cell lines27 since LRP5 was not expressed in lymphoblast cell lines. To create a reference for allelic expression in TNFRSF11B we used five intragenic SNPs (rs11573829, rs3134063, rs3548440, rs6469788, and rs10505346) in RNA and DNA samples of 55 unrelated HapMap parents (see webappendix).28
###end p 30
###begin title 31
Role of the funding source
###end title 31
###begin p 32
The sponsors of this study had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. JBR had full access to all data and JBR and TDS were jointly responsible for the decision to submit for publication.
###end p 32
###begin title 33
Results
###end title 33
###begin p 34
###xml 63 72 63 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 311 313 311 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
We identified two SNPs (rs4355801 on chromosome 8 close to the TNFRSF11B [osteoprotegerin] gene and rs3736228 on chromosome 11 in the LRP5 [low density lipoprotein-receptor-related protein] gene) for which there was genome-wide evidence for association with bone mineral density or osteoporotic fracture (p<5x10-8).
###end p 34
###begin p 35
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 126 134 126 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">figure 2</xref>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">table 3</xref>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 613 615 613 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 472 484 <span type="species:ncbi:9606">participants</span>
Several SNPs within, and in proximity to, the LRP5 gene showed strong associations with bone mineral density at lumbar spine (figure 2 and table 3). The highest ranked SNP within the locus (rs3736228) was a non-synonymous base-pair change: Ala1330Val (p=6.3x10-12 for lumbar spine, webtable 2). This SNP had the largest effect on bone mineral density, since each risk allele, T, decreased bone mineral density by 0.13 SD in the replication cohorts. 2397 (28%) of the 8557 participants had this risk allele. The T allele at rs3736228 was associated with decreased bone mineral density at the femoral neck (p=1.9x10-4). The variance in bone mineral density explained by allelic variance at rs3736228 was 0.6% for lumbar spine and 0.2% for femoral neck.
###end p 35
###begin p 36
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">table 3</xref>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
The risk allele at rs3736228 was also associated with an increased risk of osteoporotic fracture (OR 1.30, 95% CI 1.09-1.52, p=0.002 for both fracture cohorts; OR 1.59, 1.11-2.25, p=0.01 for the Chingford cohort; and OR 1.25, 1.04-1.51, p=0.02 for the Rotterdam cohort; table 3). The fracture risk imparted by rs3736228 persisted, but was partly attenuated by adjustment for bone mineral density (OR 1.22, 1.02-1.45, p=0.03). The presence of this same risk allele was associated with a greater risk of osteoporosis in the replication cohorts (OR for osteoporosis 1.33, 1.08-1.63, p=0.008). Since LRP5 is not expressed in lymphoblast cell lines we could not assess the association between this SNP and LRP5 expression.
###end p 36
###begin p 37
###xml 85 94 85 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 300 303 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;10</sup>
###xml 331 333 331 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 465 467 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 494 496 494 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 625 633 625 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">figure 3</xref>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">table 3</xref>
Three SNPs, rs4355801, rs6469792, and rs6469804, which are in close proximity to the TNFRSF11B gene, were associated with bone mineral density. The lead SNP, rs4355801, which is located in the 3' untranslated region of the gene, remained associated with bone mineral density at lumbar spine (p=7.6x10-10) and femoral neck (p=3.3x10-8), with genome-wide significance. The other two SNPs at this locus were less strongly associated with bone mineral density (p=1.1x10-6 for rs6469792 and p=6.7x10-6 for rs6469804, for lumbar spine). Many SNPs within or near this gene were associated with bone mineral density in both cohorts (figure 3). The variant with the greatest association (rs4355801) was common, and 6743 (79%) of the study population had this risk allele A. Each copy of the A risk allele was associated with a decrease in lumbar spine bone mineral density by 0.09 SD in the replication cohorts (table 3). The variance in bone mineral density explained by allelic variance at rs4355801 was 0.4% at both lumbar spine and femoral neck.
###end p 37
###begin p 38
###xml 87 96 87 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 371 380 371 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
Functional genomics investigations into the allele-specific expression patterns of the TNFRSF11B transcript in lymphoblast cell lines of HapMap individuals confirmed the relevance of the association data (webfigure 2). A clear spatial link was shown, such that the region with the strongest association with bone mineral density also most strongly affected expression of TNFRSF11B.
###end p 38
###begin p 39
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">28</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R30">30</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31">31</xref>
###xml 538 547 538 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
The strongest association was recorded for rs4355801 (p=8.3x10-6, for allelic expression association test, webtable 4).28 In quantitative analysis of 27 samples with G alleles at rs4355801, we noted a two-fold overexpression of the G allele (G:A allele ratio 2.16, 95% CI 1.4-2.9). Finally, we recorded corroborating evidence for this allelic expression association in two published datasets.30,31 In summary, the G allele at rs4355801, which was associated with higher bone mineral density, was also associated with higher expression of TNFRSF11B.
###end p 39
###begin p 40
The risk allele A at rs4355801 was associated with an increased risk of osteoporosis (OR for osteoporosis 1.20, 95% CI 1.01-1.42, p=0.038) in the replication cohorts, but no change in the risk of osteoporotic fracture (OR 1.1, 0.94-1.22 for both fracture cohorts, OR 1.1, 0.85-1.46 for the Chingford fracture cohort, OR 1.04, 0.90-1.21 for the Rotterdam fracture cohort).
###end p 40
###begin p 41
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 119 128 119 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 267 269 267 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 291 293 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 339 346 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">table 4</xref>
###xml 349 357 349 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;17</sup>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
1883 (22%) of the overall study population was homozygous or heterozygous for the risk alleles at LRP5 (rs3736228) and TNFRSF11B (rs4355801). The presence of both risk alleles was associated with a decrease in bone mineral density at lumbar spine by 0.18 SD (p=2.5x10-9) and 0.1 SD (p=7.0x10-4) at femoral neck in the replication cohorts (table 4). Figure 4 shows the cumulative effect of these risk alleles on bone mineral density at lumbar spine (p for trend=2.3x10-17) and femoral neck (p for trend=7.0x10-11). The presence of both risk alleles was associated with an increased risk of osteoporosis in the replication cohorts (OR for osteoporosis 1.5, 95% CI 1.2-2.0, p=0.0026).
###end p 41
###begin p 42
The presence of both risk alleles was associated with an increased risk of osteoporotic fracture (OR 1.33, 95% CI 1.08-1.63, p=0.006) in both the Chingford fracture cohort (OR 1.60, 1.04-2.48, p=0.03) and the Rotterdam fracture cohort (OR 1.30, 1.03-1.64, p=0.03). The association with an increased risk of fractures remained after adjustment for bone mineral density (OR 1.29, 1.05-1.59, p=0.014).
###end p 42
###begin p 43
Signals that did not reach genome-wide significance were found in other regions. The C allele at SNP rs11099284 was associated with 0.09 SD lower bone mineral density at lumbar spine (p=0.00001), and 0.07 SD at femoral neck (p=0.001). The C allele at SNP rs2445803 was associated with a decrease in femoral neck bone mineral density of 0.09 SD (p<0.0001), but had little effect on lumbar spine (0.04 SD, p=0.02). These loci could possibly affect bone mineral density, but further investigation will be needed.
###end p 43
###begin p 44
###xml 36 39 <span type="species:ncbi:9606">men</span>
We did subgroup analysis on the 784 men in the Rotterdam cohort. Although the magnitude and direction of effects of these risk alleles (rs3736228 and rs4355801) was similar to that of the overall cohorts, the confidence intervals often included the null value in this subgroup analysis. The risk allele at rs3736228 decreased bone mineral density at lumbar spine by 0.11 SD (p=0.04) but not at femoral neck (0.04 SD, p=0.42); its effect on the risk of fractures was not significant (OR 1.34, 95% CI 0.96-1.86, p=0.10). The risk allele at rs4355801 decreased bone mineral density at femoral neck by 0.10 SD (p=0.03), but did not change bone mineral density at lumbar spine (0.07 SD, p=0.10) or fracture risk (OR 1.1, 95% CI 0.86-1.4, p=0.43).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 86 92 <span type="species:ncbi:9606">people</span>
###xml 183 189 <span type="species:ncbi:9606">people</span>
We have identified genetic variants that decrease bone mineral density and predispose people to osteoporosis and osteoporotic fracture. The increased risk of osteoporotic fracture in people who had both risk alleles was independent of the effect of these alleles on bone mineral density. In combination, the risk variants at osteoprotegerin and LRP5 were common. However, since the replicated SNPs explain only a small amount of variance in bone mineral density, our findings also suggest that single common genetic variants are unlikely to have a large effect on bone mineral density.
###end p 46
###begin p 47
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R32">32</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
Physicians need the ability to assess risk factors that are prevalent, potent, and accurately quantifiable. A recent WHO meta-analysis of 60 000 individuals who were followed up for 250 000 patients-years identified bone mineral density, low body-mass index, previous fragility fractures, glucocorticoid exposure, parental history of fracture, smoking, excessive alcohol intake, and rheumatoid arthritis as common, well-replicated environmental risk factors for osteoporotic fractures.32 Although this meta-analysis was unable to ascertain the risk of osteoporotic fracture from current use of glucocorticoids, a large case-control study estimated that the relative risk was 1.33.33
###end p 47
###begin p 48
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">40</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
In our findings, the risk attributed to the presence of both genetic risk alleles was similar to or greater than all of these risk factors except prior fragility fractures and bone mineral density.34-38 However, the prevalence of both risk alleles (22%) was ten-fold higher than use of corticosteroids, and was equivalent to or exceeded all other risk factors,34-40 including osteoporosis as defined by bone mineral density.41 These alleles can be measured with near-perfect precision and without bias years before the age at which fractures tend to occur-which could provide ample lead-time for preventive measures. Eventually, a panel of genetic markers could be used in addition to environmental risk factors to identify individuals who are most at risk for osteoporotic fractures.
###end p 48
###begin p 49
###xml 83 92 83 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">42</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R43">43</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">44</xref>
We identified a novel SNP (rs4355801) in the vicinity of the osteoprotegerin gene, TNFRSF11B, which was associated with bone mineral density, osteoporosis, and expression of osteoprotegerin. This implicates osteoprotegerin as a genetic determinant of bone mineral density and osteoporosis. A previous non-replicated study of 595 individuals reported an association between SNPs in osteoprotegerin and fragility fractures, although the SNPs tested were different.42 However, data for any association with bone mineral density conflict, because of insufficiently powered study designs.43,44 We have identified a definitive genetic variant at this locus which affects osteoporosis outcomes.
###end p 49
###begin p 50
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">45</xref>
###xml 260 269 260 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 495 497 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">45</xref>
###xml 618 620 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R46">46</xref>
###xml 937 939 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R46">46</xref>
###xml 612 617 <span type="species:ncbi:9606">women</span>
###xml 796 802 <span type="species:ncbi:9606">people</span>
We used allelic expression techniques to show a possible functional role for this SNP. Osteoprotegerin plays a fundamental part in bone biology through the regulation of osteoclastogenesis, and is the target of several novel therapeutic agents.45 However, the TNFRSF11B gene has not previously been convincingly associated with bone mineral density. Osteoprotegerin acts as the natural decoy receptor to the osteoclast-derived receptor activator of nuclear factor-kappaB ligand (known as RANKL).45 Denosumab, a monoclonal antibody which mimics the action of osteoprotegerin, prevents bone loss in postmenopausal women,46 and clinical trials are underway. Furthermore, the identification of genetic variants which decrease both bone mineral density and expression of osteoprotegerin suggests that people with these variants might respond best to medications which increase osteoprotegerin concentrations. The existence of such medications46 allows the opportunity for personalised medicine on the basis of these genetic markers.
###end p 50
###begin p 51
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47">47</xref>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R48">48</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R49">49</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">50</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R51">51</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">50</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52">52</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">50</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 1026 1031 <span type="species:ncbi:9606">women</span>
###xml 1136 1139 <span type="species:ncbi:9606">men</span>
###xml 1148 1153 <span type="species:ncbi:9606">women</span>
The lead SNP in the LRP5 gene (rs3736228) was associated with decreased bone mineral density, osteoporosis, and an increased risk of osteoporotic fracture, independently of its effect on bone mineral density, which suggests that the effects of this variant on the risk of fracture can be either dependent on or independent of bone mineral density. The discovery that LRP5 affects bone mass through regulation of Wnt signalling47 was the culmination of many years of investigation, which began with the fine mapping of unusually high and low bone mineral density in some families with LRP5 mutations.48,49 SNPs in this gene have recently been shown to be related to bone mineral density50,51 and fracture.50,52 However, we used a definition of fracture that was limited to site-specific, validated, clinical, low-trauma fractures, whereas van Meurs and colleagues50 used all fractures, irrespective of trauma, validation, or site. Another SNP, rs4988300, was shown to be associated with bone mineral density at femoral neck in women (p=0.025) in a genome-wide association study for bone related traits, which assessed 71 000 SNPs in 495 men and 646 women.53 However, this study used a sample that was half the size of the TwinsUK discovery cohort; it did not replicate results; and genome coverage was four-fold lower than that in our study.
###end p 51
###begin p 52
Our study has several strengths and limitations. Although we used a hypothesis-free study design, our results are unlikely to be artifacts because the identified SNPs had a strong statistical association with bone mineral density and effects on osteoporosis and osteoporotic fracture; the identified genes had biological relevance; we used large, international, population-based cohorts; we had evidence from expression studies; and different centres used different genotyping techno logies.
###end p 52
###begin p 53
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R54">54</xref>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R55">55</xref>
###xml 1069 1071 1069 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">56</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R58">58</xref>
Although we have produced genome-wide association data for more than 300 000 SNPs, we applied conservative criteria to claim genome-wide significance. This limitation can be overcome by increased study power. Therefore, discovery cohorts with sample sizes of tens of thousands from multiple genome-wide association studies should be used to identify additional loci which could confer smaller effects. Although we used lymphoblast cell lines, rather than osteoblasts, for functional studies, lymphocytes are the main source of osteoprotegerin expression in bone marrow and the absence of B-cells causes osteoporosis.54 The identified SNPs might not be causal; however, our data for expression of osteoprotegerin do suggest a direct mechanism. Moreover, the non-synonymous LRP5 variant resides in a highly conserved domain, and similar domains in the LDL receptor are involved in binding to the receptor.55 The variance in bone mineral density explained by variance in the two identified risk alleles was small, which is similar to other genome-wide association studies,56-58 and again supports the contention that many other loci impart smaller effects on bone mineral density.
###end p 53
###begin p 54
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R59">59</xref>
In conclusion, the risk alleles we have identified justifiy further clinical and biological investigations. These SNPs alone are unlikely to change current clinical practice, but as has been shown for other diseases,59 extended panels of several SNP markers could be used in the future, in addition to traditional risk factors, to better identify populations who are at high risk for osteoporotic fractures.
###end p 54
###begin title 55
Acknowledgments
###end title 55
###begin p 56
###xml 585 597 <span type="species:ncbi:9606">participants</span>
This study was funded by the Wellcome Trust; European Commission (QLK6-CT-2002-02629, GENOMOS, GEFOS); NWO Investments (175.010.2005.011); the Arthritis Research Campaign; the Chronic Disease Research Foundation; the Canadian Institutes of Health Research (JBR); European Society for Clinical and Economic Aspects of Osteoporosis (JBR); Genome Canada (DJV, TMP); Genome Quebec (DJV, TMP); Canada Research Chairs (TMP); the National Health and Medical Research Council of Australia (SGW; 343603); and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254). We thank the study participants and staff from the TwinsUK, Chingford, and Rotterdam studies; staff of the DNA Collections and Genotyping Facilities at the Wellcome Trust Sanger Institute for sample preparation; Quality Control of the Twins UK cohort for genotyping (in particular Amy Chaney, Radhi Ravindrarajah, Douglas Simpkin, Cliff Hinds, and Thomas Dibling); Paul Martin and Simon Potter of the DNA and Genotyping Informatics teams for data handling; Le Centre National de Genotypage, France, led by Mark Lathrop, for genotyping; Duke University, North Carolina, USA, led by David Goldstein, for genotyping; and the Finnish Institute of Molecular Medicine, Finnish Genome Center, University of Helsinki, led by Aarno Palotie.
###end p 56
###begin p 57
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding</bold>
Funding Wellcome Trust, European Commission, NWO Investments, Arthritis Research Campaign, Chronic Disease Research Foundation, Canadian Institutes of Health Research, European Society for Clinical and Economic Aspects of Osteoporosis, Genome Canada, Genome Quebec, Canada Research Chairs, National Health and Medical Research Council of Australia, and European Union.
###end p 57
###begin p 58
Conflict of interest statement
###end p 58
###begin p 59
We declare that we have no conflict of interest.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Epidemiology and outcomes of osteoporotic fractures
###end article-title 61
###begin article-title 62
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation
###end article-title 62
###begin article-title 63
Assessment of fracture risk
###end article-title 63
###begin article-title 64
The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins
###end article-title 64
###begin article-title 65
The genetics of osteoporosis
###end article-title 65
###begin article-title 66
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes
###end article-title 66
###begin article-title 67
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study
###end article-title 67
###begin article-title 68
###xml 86 97 <span type="species:ncbi:9606">participant</span>
The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis
###end article-title 68
###begin article-title 69
###xml 20 25 <span type="species:ncbi:9606">human</span>
A second generation human haplotype map of over 3.1 million SNPs
###end article-title 69
###begin article-title 70
Risk of Creutzfeldt-Jakob disease in relation to animal spongiform encephalopathies: a collaborative study in Europe
###end article-title 70
###begin article-title 71
The Rotterdam Study: objectives and design update
###end article-title 71
###begin article-title 72
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study
###end article-title 72
###begin article-title 73
The association between osteoarthritis and osteoporotic fracture: the Chingford Study
###end article-title 73
###begin article-title 74
Updated data on proximal femur bone mineral levels of US adults
###end article-title 74
###begin article-title 75
###xml 72 75 <span type="species:ncbi:9606">men</span>
###xml 80 85 <span type="species:ncbi:9606">women</span>
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study
###end article-title 75
###begin article-title 76
Promoter and 3'-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study
###end article-title 76
###begin article-title 77
###xml 119 122 <span type="species:ncbi:9606">men</span>
The catechol-O-methyltransferase Met158 low-activity allele and association with nonvertebral fracture risk in elderly men
###end article-title 77
###begin article-title 78
Inference of population structure using multilocus genotype data
###end article-title 78
###begin article-title 79
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
###end article-title 79
###begin article-title 80
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies
###end article-title 80
###begin article-title 81
Genomewide association analysis of coronary artery disease
###end article-title 81
###begin article-title 82
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 82
###begin article-title 83
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 83
###begin article-title 84
Estimation of significance thresholds for genomewide association scans
###end article-title 84
###begin article-title 85
A Wilcoxon-type test for trend
###end article-title 85
###begin article-title 86
###xml 39 44 <span type="species:ncbi:9606">human</span>
Cis-acting regulatory variation in the human genome
###end article-title 86
###begin article-title 87
###xml 20 25 <span type="species:ncbi:9606">human</span>
A second generation human haplotype map of over 3.1 million SNPs
###end article-title 87
###begin article-title 88
###xml 38 43 <span type="species:ncbi:9606">human</span>
Mapping common regulatory variants to human haplotypes
###end article-title 88
###begin article-title 89
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 89
###begin article-title 90
###xml 23 28 <span type="species:ncbi:9606">human</span>
Population genomics of human gene expression
###end article-title 90
###begin article-title 91
###xml 56 62 <span type="species:ncbi:9606">humans</span>
Genome-wide analysis of transcript isoform variation in humans
###end article-title 91
###begin article-title 92
###xml 51 54 <span type="species:ncbi:9606">men</span>
###xml 59 64 <span type="species:ncbi:9606">women</span>
FRAX and the assessment of fracture probability in men and women from the UK
###end article-title 92
###begin article-title 93
Use of oral corticosteroids and risk of fractures
###end article-title 93
###begin article-title 94
Body mass index as a predictor of fracture risk: a meta-analysis
###end article-title 94
###begin article-title 95
A family history of fracture and fracture risk: a meta-analysis
###end article-title 95
###begin article-title 96
Smoking and fracture risk: a meta-analysis
###end article-title 96
###begin article-title 97
Alcohol intake as a risk factor for fracture
###end article-title 97
###begin article-title 98
A meta-analysis of prior corticosteroid use and fracture risk
###end article-title 98
###begin article-title 99
Special groups of smokers
###end article-title 99
###begin article-title 100
Use of oral corticosteroids in the United Kingdom
###end article-title 100
###begin article-title 101
Changes to osteoporosis prevalence according to method of risk assessment
###end article-title 101
###begin article-title 102
Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures
###end article-title 102
###begin article-title 103
###xml 146 149 <span type="species:ncbi:9606">men</span>
Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men
###end article-title 103
###begin article-title 104
###xml 114 119 <span type="species:ncbi:9606">women</span>
No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women
###end article-title 104
###begin article-title 105
Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases
###end article-title 105
###begin article-title 106
###xml 28 33 <span type="species:ncbi:9606">women</span>
Denosumab in postmenopausal women with low bone mineral density
###end article-title 106
###begin article-title 107
Regulation of bone mass by Wnt signaling
###end article-title 107
###begin article-title 108
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
###end article-title 108
###begin article-title 109
Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13
###end article-title 109
###begin article-title 110
###xml 137 140 <span type="species:ncbi:9606">men</span>
Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men
###end article-title 110
###begin article-title 111
Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes
###end article-title 111
###begin article-title 112
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis
###end article-title 112
###begin article-title 113
Genome-wide association with bone mass and geometry in the Framingham Heart Study
###end article-title 113
###begin article-title 114
B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo
###end article-title 114
###begin article-title 115
Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins
###end article-title 115
###begin article-title 116
LDL-cholesterol concentrations: a genome-wide association study
###end article-title 116
###begin article-title 117
A common variant of HMGA2 is associated with adult and childhood height in the general population
###end article-title 117
###begin article-title 118
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity
###end article-title 118
###begin article-title 119
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration
###end article-title 119
###begin title 120
Figures and Tables
###end title 120
###begin title 121
Study design
###end title 121
###begin p 122
SNP=single nucleotide polymorphism. *TwinsUK Discovery cohort. daggerSubsample of the Rotterdam cohort. double daggerTwinsUK replication cohort, Chingford cohort, and the remainder of the Rotterdam cohort. section signRotterdam fracture cohort. paragraph signChingford fracture cohort.
###end p 122
###begin title 123
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
Association of single nucleotide polymorphisms at LRP5 with bone mineral density in the lumbar spine
###end title 123
###begin p 124
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">29</xref>
(A) Negative log p values for associations between the SNP, rs3736228, and bone mineral density are plotted against chromosomal position. (B) Annotated reference sequence genes by chromosomal position (according to the US National Centre for Biotechnology Information). (C) Linkage disequilibrium in GOLD heatmap Haploview 4.0 colour scheme.29 SNP rs3736228 represents data from all cohorts. Details of all SNPs are in webtable 3.
###end p 124
###begin title 125
###xml 78 87 78 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
Association of single nucleotide polymorphisms near the osteoprotegerin gene (TNFRSF11B) and bone mineral density at lumbar spine
###end title 125
###begin p 126
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">29</xref>
(A) Negative log p values for associations between the SNP, rs4355801, and bone mineral density are plotted against chromosomal position. (B) Annotated reference sequence genes by chromosomal position (according to the US National Center for Biotechnology Information). (C) Linkage disequilibrium in GOLD heatmap Haploview 4.0 colour scheme.29 SNPs rs4355801, rs6469792, and rs6469804 represent data from all cohorts. Details of all SNPs in this figure are in webtable 3.
###end p 126
###begin title 127
###xml 51 60 51 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF11B</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
Bone mineral density and number of risk alleles at TNFRSF11B (rs6469792) and LRP5 (rs3736228)
###end title 127
###begin p 128
Bone mineral density at (A) lumbar spine and (B) femoral neck. Vertical bars represent standard errors. p value is from the non-parametric trend test. The data represent all cohorts studied.
###end p 128
###begin p 129
Characteristics of 8557 genotyped individuals assessed for bone mineral density and osteoporosis
###end p 129
###begin p 130
Data are mean (SD) or number (%).
###end p 130
###begin p 131
Characteristics of 6639 genotyped individuals assessed for osteoporotic fractures
###end p 131
###begin p 132
Data are mean (SD) or number (%).
###end p 132
###begin p 133
Osteoporotic fractures were defined as site-specific, validated, clinical, or low-trauma fractures.
###end p 133
###begin p 134
###xml 8 14 <span type="species:ncbi:9606">people</span>
Not all people followed up for fracture had measurements of bone mineral density.
###end p 134
###begin p 135
Association between two single nucleotide polymorphisms and bone mineral density at lumbar spine
###end p 135
###begin p 136
Effect is the additive effect of each risk allele on the standardised residual for bone mineral density (residualised for age) in the replication cohorts.
###end p 136
###begin p 137
Effect of both single nucleotide polymorphisms on bone mineral density at lumbar spine, osteoporotic fracture, and osteoporosis
###end p 137
###begin p 138
Effect in the 22% of individuals with both risk alleles.
###end p 138
###begin p 139
Combined p value is for the discovery, stage 1, and stage 2 replication samples.
###end p 139

